关键词: Antiviral therapy Bulevirtide Delta hepatitis Hepatitis B Hepatitis D virus Lonafarnib

来  源:   DOI:10.1007/s11901-024-00643-w   PDF(Pubmed)

Abstract:
UNASSIGNED: Hepatitis D Virus (HDV), although a small defective virus, poses a substantial public health challenge due to lack of awareness, underrecognized prevalence, and limited treatment options. Universal HDV screening within hepatitis B virus (HBV) cohorts is essential to address this issue. Despite its aggressive nature, effective HDV therapies have remained elusive for over four decades.
UNASSIGNED: Advances in understanding HDV\'s biology and clinical behavior offer potential therapeutic breakthroughs, fostering optimism. As insights grow, effective and targeted therapies are being developed to improve HDV management.
UNASSIGNED: This review delves into HDV\'s intricate structure and biology, highlighting formidable hurdles in antiviral development. It emphasizes the importance of widespread screening, exploring noninvasive diagnostics, and examining current and emerging innovative therapeutic strategies. Moreover, the review explores models for monitoring treatment response. In essence, this review simplifies the complexities of effectively combating HDV.
摘要:
丁型肝炎病毒(HDV),虽然是一种有缺陷的小病毒,由于缺乏意识,构成了重大的公共卫生挑战,被低估的患病率,和有限的治疗选择。乙型肝炎病毒(HBV)队列中的通用HDV筛查对于解决此问题至关重要。尽管它具有侵略性,有效的HDV疗法在过去40年中一直难以捉摸。
了解HDV生物学和临床行为的进展提供了潜在的治疗突破,培养乐观情绪。随着洞察力的增长,正在开发有效和有针对性的治疗方法来改善HDV管理。
这篇综述深入探讨了HDV复杂的结构和生物学,突出抗病毒开发中的巨大障碍。它强调了广泛筛查的重要性,探索非侵入性诊断,并研究当前和新兴的创新治疗策略。此外,这篇综述探讨了监测治疗反应的模型.实质上,这篇评论简化了有效对抗HDV的复杂性。
公众号